NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

MHRA will approve DC-Vax. The soon-to-be-released UCLA combination study will show greater than 50% long-term survival of GBM patients. The FDA will not refuse to give GBP patients fantastic odds of conquering GBM because they are not criminally insane. The voices of the frontline oncologists and, above all else, the voices of the patients in the US will demand that the FDA approve DC-Vax. And they will. You can take that to the bank, and we will.

You guys are smart enough to understand this but you will never stop lying to get a paycheck. You dishonor yourselves every day.